Daniel C. Martin is Senior Vice President and Chief Commercial Officer at Deciphera Pharmaceuticals. Mr. Martin joined Deciphera in 2018 and has more than 20 years of commercial experience within the biopharmaceutical industry with extensive background in oncology and immuno-oncology. Prior to joining Deciphera, he served as Senior Vice President, Commercial at Heron Therapeutics where he built the company’s commercial organization, including establishing marketing, sales, and market access functions, and launched its oncology portfolio. Mr. Martin also served as commercial lead for Heron’s portfolio strategy and new product planning across all therapeutic areas. Before joining Heron, Mr. Martin held commercial leadership positions at Dendreon and at Amgen, where he played lead roles in multiple U.S. and global oncology launches. Earlier in his career, Mr. Martin was a management consultant with Deloitte Consulting where he advised global biopharmaceutical companies in commercial strategy and operations. Mr. Martin received a B.A. with honors in economics and biology from the University of Virginia and an M.B.A. from the Wharton School at the University of Pennsylvania.